Synergy pharmaceuticals stock analysis
SYNERGY PHARMACEUTICALS INC : Stock Price | MarketScreener Synergy Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of novel gastrointestinal (GI) therapies. Its gastrointestinal (GI) platform is based on uroguanylin. SGYP / Synergy Pharmaceuticals, Inc. Overview - (871639308 ... Split History. Stock splits are used by Synergy Pharmaceuticals, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an … SGYP Stock Quote of Synergy Pharma Synergy Pharmaceuticals (SGYP) a Sell at recent price of $2.47, on Adverse Sales Growth By Portfolio Grader Jan 26, 2018 The a Sell rating for SGYP is based on the Portfolio Grader stock evaluator.
Synergy Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of novel gastrointestinal (GI) therapies. Its gastrointestinal (GI) platform is based on uroguanylin.
Synergy Pharmaceuticals Inc. is headquartered in New York, New York. On December 12, 2018, Synergy Pharmaceuticals Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York. Synergy Pharmaceuticals Inc. (SGYP) - Yahoo SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Encourages Investors … Synergy Pharmaceuticals - SGYP - Stock Price & News | The ... Apr 04, 2020 · Real time Synergy Pharmaceuticals (SGYP) stock price quote, stock graph, news & analysis. SGYP Stock | SYNERGY PHARMACEUTICALS Stock Price Today ... Mar 08, 2019 · SGYP: Get the latest Synergy Pharmaceuticals stock price and detailed information including SGYP news, historical charts and realtime prices.
Synergy Pharmaceuticals, Inc. – Value Analysis (NASDAQ ...
NASDAQ:SGYP Synergy Pharmaceuticals Inc. - Stock Market Mentor
This page contains all of the latest analysis and reports for the Synergy Pharmaceuticals Inc stock.
Synergy Pharmaceuticals, Inc. – Value Analysis (NASDAQ ...
Synergy Pharmaceuticals Announces Completion of Sale to ...
Company profile page for Synergy Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information. Skip To Content. NASDAQ | SGYP: Stock News, Ratings & Analysis for Synergy ... Looking for insights on Synergy-pharma (NASDAQ:SGYP) stock? View SGYP's stock ratings, price targets, earnings, commentary and news at Smarter Analyst. Synergy Pharmaceuticals Stock Forecast: down to 0.000001 ... Historical index on US Stock Market : D "Should I invest in Synergy Pharmaceuticals stock?" "Should I trade "SGYP" stock today?" According to our live Forecast System, Synergy Pharmaceuticals Inc stock is a bad long-term (1-year) investment*. "SGYP" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. NASDAQ:SGYP Synergy Pharmaceuticals Inc. - Stock Market Mentor Synergy Pharmaceuticals, Inc., is a biopharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders and diseases. Its lead product candidate is plecanatide. Request Video of SGYP Already a member? Sign in here.
Oct 03, 2017 · Synergy Pharmaceuticals Inc.SGYP was a big mover last session, as the company saw its shares rise more than 12% on the day. The move came on solid. Free Stock Analysis Report. Is Synergy Pharmaceuticals Inc (NASDAQ:SGYP) A Volatile Stock? Nov 02, 2018 · A stock with a beta below one is either less volatile than the market, or more volatile but not corellated with the overall market. In comparison a stock with a beta of over one tends to be move in a similar direction to the market in the long term, but with greater changes in price. Check out our latest analysis for Synergy Pharmaceuticals Analysis of top Seeking Alpha coverage: Synergy FedEx Rising After Amazon Lifts Ban on FedEx Ground for Third-Party Prime Shipments: FedEx Corp. (FDX) shares were higher in afternoon trading, recently up 3% to $163.60 after Amazon.com Inc.(AMZN) lifted its ban on FedEx Ground for third-party prime shipments. SGYP - Synergy Pharma Stock Price - Barchart.com